Total Payments
$490,103
2024 Payments
$74,705
Companies
34
Transactions
1,388
Medicare Patients
1,446
Medicare Billing
$171,419
Payment Breakdown by Category
Other$388,254 (79.2%)
Consulting$41,399 (8.4%)
Travel$39,819 (8.1%)
Food & Beverage$19,980 (4.1%)
Education$650.90 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $386,504 | 205 | 78.9% |
| Consulting Fee | $41,399 | 26 | 8.4% |
| Travel and Lodging | $39,819 | 164 | 8.1% |
| Food and Beverage | $19,980 | 961 | 4.1% |
| Honoraria | $1,750 | 1 | 0.4% |
| Education | $650.90 | 31 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $410,866 | 821 | $0 (2024) |
| Janssen Biotech, Inc. | $28,609 | 39 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $11,968 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $8,371 | 75 | $0 (2024) |
| UCB, Inc. | $7,959 | 33 | $0 (2023) |
| GENZYME CORPORATION | $5,711 | 6 | $0 (2023) |
| Regeneron Pharmaceuticals, Inc. | $5,621 | 15 | $0 (2019) |
| PFIZER INC. | $4,488 | 82 | $0 (2023) |
| Amgen Inc. | $2,647 | 167 | $0 (2024) |
| Janssen Global Services, LLC | $1,400 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $74,705 | 114 | ABBVIE INC. ($74,348) |
| 2023 | $90,137 | 148 | AbbVie Inc. ($46,024) |
| 2022 | $100,182 | 237 | ABBVIE INC. ($85,334) |
| 2021 | $55,846 | 160 | AbbVie Inc. ($49,922) |
| 2020 | $42,092 | 121 | AbbVie Inc. ($37,226) |
| 2019 | $77,040 | 235 | AbbVie, Inc. ($70,494) |
| 2018 | $20,890 | 163 | AbbVie, Inc. ($19,493) |
| 2017 | $29,210 | 210 | AbbVie, Inc. ($28,025) |
All Payment Transactions
1,388 individual payment records from CMS Open Payments — Page 1 of 56
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $370.67 | General |
| Category: IMMUNOLOGY | ||||||
| 12/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Travel and Lodging | In-kind items and services | $260.10 | General |
| Category: IMMUNOLOGY | ||||||
| 12/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: Inflammation | ||||||
| 12/06/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $787.50 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,575.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,675.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | ABBVIE INC. | RINVOQ (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Dermatology | ||||||
| 11/08/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.03 | General |
| Category: Immunology | ||||||
| 11/07/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $5.08 | General |
| Category: IMMUNOLOGY | ||||||
| 11/04/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: IMMUNOLOGY | ||||||
| 10/25/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $26.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Travel and Lodging | In-kind items and services | $157.25 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $93.60 | General |
| Category: IMMUNOLOGY | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $62.08 | General |
| Category: IMMUNOLOGY | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 7 | 316 | 495 | $53,701 | $22,196 |
| 2021 | 9 | 592 | 2,603 | $153,470 | $79,436 |
| 2020 | 12 | 538 | 2,700 | $148,372 | $69,788 |
Total Patients
1,446
Total Services
5,798
Medicare Billing
$171,419
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 157 | $26,330 | $11,839 | 45.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 101 | 116 | $13,701 | $5,470 | 39.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 30 | 30 | $7,435 | $2,920 | 39.3% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 18 | 24 | $3,290 | $994.67 | 30.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 14 | 86 | $2,615 | $844.27 | 32.3% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 12 | 22 | $210.00 | $95.72 | 45.6% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 14 | 60 | $120.00 | $32.79 | 27.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 239 | 369 | $60,885 | $31,869 | 52.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 18 | 1,560 | $45,240 | $25,975 | 57.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 146 | 178 | $20,344 | $10,528 | 51.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 45 | 45 | $11,250 | $5,144 | 45.7% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2021 | 36 | 55 | $7,360 | $2,766 | 37.6% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 32 | 168 | $5,208 | $1,782 | 34.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 14 | 14 | $2,300 | $994.69 | 43.2% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2021 | 28 | 48 | $480.00 | $212.76 | 44.3% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2021 | 34 | 166 | $403.00 | $163.96 | 40.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2020 | 15 | 1,740 | $50,460 | $26,951 | 53.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 175 | 308 | $49,416 | $22,750 | 46.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 107 | 141 | $15,679 | $6,806 | 43.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 56 | 56 | $13,566 | $5,881 | 43.4% |
| 20610 | Aspiration and/or injection of large joint or joint capsule | Office | 2020 | 40 | 56 | $7,001 | $2,659 | 38.0% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 22 | 22 | $3,539 | $1,632 | 46.1% |
| 20600 | Aspiration and/or injection of small joint or joint capsule | Office | 2020 | 17 | 42 | $4,110 | $1,261 | 30.7% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 20 | 74 | $2,325 | $793.11 | 34.1% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 14 | 17 | $1,133 | $563.02 | 49.7% |
About Brett Smith
Brett Smith is a Rheumatology healthcare provider based in Knoxville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/09/2010. The National Provider Identifier (NPI) number assigned to this provider is 1316265887.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brett Smith has received a total of $490,103 in payments from pharmaceutical and medical device companies, with $74,705 received in 2024. These payments were reported across 1,388 transactions from 34 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($386,504).
As a Medicare-enrolled provider, Smith has provided services to 1,446 Medicare beneficiaries, totaling 5,798 services with total Medicare billing of $171,419. Data is available for 3 years (2020–2022), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Rheumatology
- Location Knoxville, TN
- Active Since 05/09/2010
- Last Updated 02/14/2025
- Taxonomy Code 207RR0500X
- Entity Type Individual
- NPI Number 1316265887
Products in Payments
- RINVOQ (Biological) $211,183
- Humira (Biological) $39,905
- Rinvoq (Biological) $31,226
- SKYRIZI (Biological) $30,110
- RINVOQ (Drug) $28,721
- SIMPONI ARIA (Biological) $27,068
- KEVZARA (Biological) $10,592
- TREMFYA (Drug) $9,043
- HUMIRA (Biological) $8,962
- ILARIS (Drug) $5,916
- STELARA (Biological) $5,788
- XELJANZ (Drug) $4,408
- Enbrel (Biological) $2,224
- ILARIS (Biological) $1,592
- COSENTYX (Biological) $738.03
- Cimzia (Drug) $575.38
- TALTZ (Drug) $302.36
- KEVZARA SARILUMAB INJECTION (Biological) $301.22
- Bimzelx (Biological) $251.15
- ORENCIA (Biological) $204.12
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Rheumatology Doctors in Knoxville
Kenny Sizemore, Md, MD
Rheumatology — Payments: $29,566
Rheumatology $29,566
Dr. Jay Warrick, M.d, M.D
Rheumatology — Payments: $17,724
Rheumatology $17,724
James Burns, Md, MD
Rheumatology — Payments: $14,099
Rheumatology $14,099
Tonya Baker, M.d, M.D
Rheumatology — Payments: $12,682
Rheumatology $12,682
Dr. Robert Capps, M.d, M.D
Rheumatology — Payments: $12,415
Rheumatology $12,415
Mr. William Bush, M.d, M.D
Rheumatology — Payments: $9,164
Rheumatology $9,164